Volume | 11,546,968 |
|
|||||
News | - | ||||||
Day High | 10.36 | Low High |
|||||
Day Low | 9.74 |
Company Name | Etf Ticker Symbol | Market | Type |
---|---|---|---|
Advisorshares Pure Us Cannabis Etf | MSOS | AMEX | Exchange Traded Fund |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
10.10 | 9.74 | 10.36 | 10.01 | 10.18 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
40,751 | 11,546,968 | 10.03 | 115,825,454 | - | 4.78 - 10.64 |
Last Trade Time | Type | Quantity | Etf Price | Currency |
---|---|---|---|---|
19:14:34 | formt | 176 | 10.00 | USD |
Advisorshares Pure Us Ca... (MSOS) Options Flow Summary
Advisorshares Pure Us Cannabis Etf Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.09B | - | - | - | 12.38 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News Advisorshares Pure Us Ca...
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
MSOS Historical
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 9.08 | 10.36 | 8.77 | 9.65 | 11,001,155 | 0.92 | 10.13% |
1 Month | 8.85 | 10.36 | 7.30 | 8.81 | 8,990,643 | 1.15 | 12.99% |
3 Months | 7.20 | 10.64 | 7.04 | 8.89 | 7,820,153 | 2.80 | 38.89% |
6 Months | 8.10 | 10.64 | 4.92 | 7.84 | 6,891,884 | 1.90 | 23.46% |
1 Year | 5.88 | 10.64 | 4.78 | 7.44 | 5,397,540 | 4.12 | 70.07% |
3 Years | 42.52 | 44.68 | 4.78 | 10.97 | 2,762,306 | -32.52 | -76.48% |
5 Years | 24.90 | 55.91 | 4.78 | 12.32 | 2,421,928 | -14.90 | -59.84% |
The investment seeks long-term capital appreciation. The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology and life sciences industry group within the health care sector. The fund is non-diversified. |